Showing results (351-360 of 362) with videos related to

Sort By:
Pageof 37
Biomedicines|September 28, 2021
Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal ModelsAmira D Rghei, Laura P van Lieshout, Benjamin M McLeod, et al.
Journal of Medicinal Chemistry|July 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-LactamasesThomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang, et al.
The Lancet Regional Health. Europe|September 24, 2021
Optimising antimicrobial use in humans - review of current evidence and an interdisciplinary consensus on key priorities for researchEsmita Charani, Martin McKee, Raheelah Ahmad, et al.
Nature Ecology & Evolution|January 14, 2022
Ecological network complexity scales with areaNúria Galiana, Miguel Lurgi, Vinicius A G Bastazini, et al.
Nature Microbiology|July 1, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumanniiThomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2024
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian CancerYoung Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Journal of Pediatric Orthopedics|June 12, 2013
Building consensus: development of a Best Practice Guideline (BPG) for surgical site infection (SSI) prevention in high-risk pediatric spine surgeryMichael G Vitale, Matthew D Riedel, Michael P Glotzbecker, et al.
Nature|September 16, 2021
Rational design of a new antibiotic class for drug-resistant infectionsThomas F Durand-Reville, Alita A Miller, John P O'Donnell, et al.
Journal for Immunotherapy of Cancer|February 11, 2026
DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervixYoung Kwang Chae, Megan Othus, Sandip P Patel, et al.
Osteoarthritis and Cartilage Open|December 10, 2025
Corrigendum to "The PIKASO trial (Preventing Injured Knees from Osteoarthritis: Severity Outcomes): Rationale and design features for a randomized controlled trial" [Osteoarthr Cartil Open 7 (2025) 100563]Cale A Jacobs, Morgan H Jones, Jamie E Collins, et al.
Pageof 37